Technology | Enterprise Imaging | March 20, 2017

Agfa HealthCare Releases Newest Version of Enterprise Imaging for Cardiology at ACC.17

Company also displayed early concept for collaboration with IBM Watson Health for automated structure reporting based on natural language processing and cognitive analytics

Agfa HealthCare, Enterprise Imaging for Cardiology, ACC.17, IBM Watson Health

March 20, 2017 — Agfa HealthCare announced the release a new version of its Enterprise Imaging for Cardiology platform at the American College of Cardiology ACC.17 expo, March 17-19 in Washington, D.C. Customer-driven enhancements include new structured reporting modules for congenital echocardiology and nuclear cardiology.

The suite is part of the Enterprise Imaging converged platform, which offers a care-centric workflow that is standards-based, improves interoperability and enables a comprehensive patient health record across departments within a single facility or between multiple facilities.

With Enterprise Imaging for Cardiology, cardiologists have a robust environment providing a single point of access to patient information from different sources. They can quickly retrieve a patient's complete cardiology file, generate a report and distribute it, all during one session, even from a remote location. Images, reports and relevant, sophisticated toolkits are supported by the task-based workflow that aligns with and supports their clinical workflow.

The new features provide support for congenital echocardiology and nuclear cardiology, deeply integrated into the Enterprise Imaging platform.

At ACC.17, Agfa HealthCare also showed an early concept for automated structured reporting based on natural language processing (NLP) and cognitive analytics, a work in progress in collaboration with IBM Watson Health. This collaboration illustrated how clinicians may be able to use normal dictation methods for reporting and still achieve structured report, as well as structured data using a natural language processing and cognition-based algorithm powered by IBM Watson, to convert dictated reports into structured data.

For more information: www.agfahealthcare.com

Related Content

the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock
Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Siemens Healthineers Supports Population Health Management With Planned Acquisition of Medicalis
News | Clinical Decision Support| April 19, 2017
Siemens Healthineers plans to expand its Population Health Management (PHM) portfolio with the acquisition of Medicalis...

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
Sponsored Content | Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Sponsored Content | Videos | Analytics Software| April 13, 2017
The shift to value-based payment models requires focused attention on quality and cost.
Sponsored Content | Videos | EP Lab| April 10, 2017
A discussion with Heart Rhythm Society (HRS) President Michael Gold, M.D., Ph.D., director of cardiology and associat
EBBINGHAUS study, evolocumab, repatha, statin therapy, cognitive issues, ACC.17 study
News | Pharmaceuticals| April 03, 2017
There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other...
Henry Ford Hospital, Detroit Cardiogenic Shock Initiative, Impella pump, ACC.17 clinical study
News | Ventricular Assist Devices (VAD)| April 03, 2017
Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic shock by providing...
RenalGuard Therapy, ACC.17, meta-analysis, contrast-induced acute kidney injury, CI-AKI
News | Cath Lab| April 03, 2017
A new meta-analysis further supports the ability of RenalGuard Therapy to significantly reduce the incidence of acute...
Overlay Init